MDPI开放科学
聚焦肝病学领域研究——Livers
2025-10-11 16:59
阅读:644

期刊简介

Livers (ISSN 2673-4389) 创刊于2021年,最新Impact Factor 2.4,CiteScore 3.2,是一个国际性、经同行评审的开放获取期刊。期刊旨在为肝病学的基础、转化和高级临床研究提供一个平台,鼓励科学家尽可能详细地发表他们的实验和理论成果。此外,期刊也发表最新、最相关的文献综述。

期刊主页:https://www.mdpi.com/journal/livers

             

2024 Impact Factor: 2.4

2024 CiteScore: 3.2

Time to First Decision: 27.8 Days

Acceptance to Publication: 6.7 Days

             

期刊Scope

期刊内容涉及肝脏与胆道科学,主题范围包括:

• 肝炎 (所有形式)

• 酒精性肝病

• 非酒精性脂肪性肝病 (NAFLD) 和非酒精性脂性肝炎 (NASH)

• 肝硬化

• 胆道疾病

• 药物性肝损伤

• 遗传性和代谢性肝病及其并发症

• 癌症与药物代谢

• 肝细胞癌

• 肝纤维化

• 肝病免疫学

• 肝病学营养

• 肝病病理学

• 肝病的诊断和治疗

             

期刊主编

Prof. Dr. Hartmut W. Jaeschke

University of Kansas Medical Center, USA

             

精选文章

1. Acetaminophen-Induced Hepatotoxicity in Obesity and Nonalcoholic Fatty Liver Disease: A Critical Review

对乙酰氨基酚在肥胖和非酒精性脂肪性肝病中的肝毒性:一项综述

Karima Begriche et al.

https://www.mdpi.com/2067192

             

2. Hidden Dangers: Herbal and Dietary Supplement Induced Hepatotoxicity

隐患:草药和膳食补充剂诱发的肝毒性

Jonathan Kwong-Shing Lin and Shannan R. Tujios

https://www.mdpi.com/2543560

             

3. The Epidemiology of Chronic Hepatitis C: Where We Are Now

慢性丙型肝炎的流行病学:现状

Cristina Stasi et al.

https://www.mdpi.com/2734520

             

4. Advancements in Understanding and Treating NAFLD: A Comprehensive Review of Metabolic-Associated Fatty Liver Disease and Emerging Therapies

NAFLD理解和治疗的进展:代谢相关脂肪性肝病和新兴疗法的综合综述

Jacob Beiriger et al.

https://www.mdpi.com/2551276

             

5. The Evolution of Circulating Biomarkers for Use in Acetaminophen/Paracetamol-Induced Liver Injury in Humans: A Scoping Review

用于对乙酰氨基酚/扑热息痛诱导的人类肝损伤的循环生物标志物的进展:范围综述

Mitchell R. McGill and Steven C. Curry

https://www.mdpi.com/2536894

             

6. The Pivotal Role of the Membrane-Bound O-Acyltransferase Domain Containing 7 in Non-Alcoholic Fatty Liver Disease

膜结合O-酰基转移酶结构域7在非酒精性脂肪肝中的关键作用

Preethi Chandrasekaran and Ralf Weiskirchen

https://www.mdpi.com/2607148

             

特刊推荐

1. The Surveillance, Prevention, and Treatment of Viral Hepatitis: Looking Forward to Global Elimination

Edited by Melanie Deutsch

Submission Deadline: 31 October 2025

https://www.mdpi.com/si/239384

             

2. Mechanistic and Prognostic Biomarkers in Liver Diseases

Edited by Hartmut W. Jaeschke and Mitchell R. McGill

Submission Deadline: 30 November 2025

https://www.mdpi.com/si/242195

             

3. Liver Cancer Heterogeneity in the Era of Single-Cell and Spatial Multiomics

Edited by Veronika Lukacs-Kornek and Ralf Weiskirchen

Submission Deadline: 30 December 2025

https://www.mdpi.com/si/246284

             

4. Recent Advances in the Detection and Pathophysiology of Steatotic, Alcoholic and Drug-Induced Liver Diseases

Edited by Leonard Nelson and Michel Kranendonk

Submission Deadline: 31 December 2025

https://www.mdpi.com/si/219779

             

5. Liver Macrophage Diversity and Functions in MASLD and ALD

Edited by Adeline Bertola

Submission Deadline: 10 March 2026

https://www.mdpi.com/si/233264

             

作者指南

如您对投稿有任何疑问,欢迎阅读作者指南 (https://www.mdpi.com/journal/livers/instructions),或联系 Livers 期刊编辑部 (livers@mdpi.com)。

1.jpg

2.jpg

转载本文请联系原作者获取授权,同时请注明本文来自MDPI开放科学科学网博客。

链接地址:https://wap.sciencenet.cn/blog-3516770-1505552.html?mobile=1

收藏

当前推荐数:0
推荐到博客首页
网友评论0 条评论
确定删除指定的回复吗?
确定删除本博文吗?